One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1016/j.annonc.2023.10.319
Copy DOI Journal: Annals of Oncology |  Publication Date: Nov 1, 2023 |
Affiliation: Sidney Kimmel Cancer Center, The Maria Sklodowska-Curie National Research Institute of Oncology, Seoul National University Hospital, Vall d'Hebron Institute of Oncology, University of Sydney, National Taiwan University Hospital, Ramathibodi Hospital, The University of Texas MD Anderson Cancer Center, University of Colorado Anschutz Medical Campus604P Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who progressed after prior VEGFR-targeted therapy: Outcomes from COSMIC-311 by BRAF status
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
